HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Rycroft Selected Research

Tachykinins

2/2000The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Rycroft Research Topics

Disease

2Vomiting
03/2000 - 02/2000
1Inflammation (Inflammations)
03/2000
1Neoplasms (Cancer)
02/2000

Drug/Important Bio-Agent (IBA)

2Cisplatin (Platino)FDA LinkGeneric
03/2000 - 02/2000
2ProdrugsIBA
03/2000 - 02/2000
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
03/2000
1antineoplaston A10 (A 10)IBA
03/2000
1Aprepitant (Emend)FDA Link
02/2000
1L 758298IBA
02/2000
1AntiemeticsIBA
02/2000
1TachykininsIBA
02/2000

Therapy/Procedure

1Intravenous Administration
03/2000
1Drug Therapy (Chemotherapy)
02/2000